Evidence map›Paper›PMID 39107322›Full record

ArticleNature communications2024

eIF4E-independent translation is largely eIF3d-dependent.

Mykola Roiuk, Marilena Neff, Aurelio A Teleman

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Enhancement of Therapeutic mRNA Translation in Cellular Stress Conditions.International journal of molecular sciences · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mykola RoiukGerman Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.ORCID 0000-0001-5225-4422
Marilena NeffGerman Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.
Aurelio A TelemanGerman Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany. a.teleman@dkfz.de.ORCID 0000-0002-4237-9368

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Translation initiation is a highly regulated step needed for protein synthesis. Most cell-based mechanistic work on translation initiation has been done using non-stressed cells growing in medium with sufficient nutrients and oxygen. This has yielded our current understanding of 'canonical' translation initiation, involving recognition of the mRNA cap by eIF4E1 followed by successive recruitment of initiation factors and the ribosome. Many cells, however, such as tumor cells, are exposed to stresses such as hypoxia, low nutrients or proteotoxic stress. This leads to inactivation of mTORC1 and thereby inactivation of eIF4E1. Hence the question arises how cells translate mRNAs under such stress conditions. We study here how mRNAs are translated in an eIF4E1-independent manner by blocking eIF4E1 using a constitutively active version of eIF4E-binding protein (4E-BP). Via ribosome profiling we identify a subset of mRNAs that are still efficiently translated when eIF4E1 is inactive. We find that these mRNAs preferentially release eIF4E1 when eIF4E1 is inactive and bind instead to eIF3d via its cap-binding pocket. eIF3d then enables these mRNAs to be efficiently translated due to its cap-binding activity. In sum, our work identifies eIF3d-dependent translation as a major mechanism enabling mRNA translation in an eIF4E-independent manner.

Indexed as

Eukaryotic Initiation Factor-3Eukaryotic Initiation Factor-4EProtein BiosynthesisRibosomesRNA, MessengerAdaptor Proteins, Signal TransducingCell Cycle ProteinsHEK293 CellsHumansPeptide Chain Initiation, TranslationalProtein BindingRNA CapsAdaptor Proteins, Signal TransducingCell Cycle ProteinsEIF3D protein, humanEIF4EBP1 protein, humanEIF4E protein, humanEukaryotic Initiation Factor-3Eukaryotic Initiation Factor-4ERNA CapsRNA, Messenger

Identifiers

PMID39107322
PMCPMC11303786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.